These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30453020)

  • 1. Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neurons.
    Wong R; Lénárt N; Hill L; Toms L; Coutts G; Martinecz B; Császár E; Nyiri G; Papaemmanouil A; Waisman A; Müller W; Schwaninger M; Rothwell N; Francis S; Pinteaux E; Denés A; Allan SM
    Brain Behav Immun; 2019 Feb; 76():126-138. PubMed ID: 30453020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1R1 signaling in TBI: assessing chronic impacts and neuroinflammatory dynamics in a mouse model of mild closed-head injury.
    Vincent JC; Garnett CN; Watson JB; Higgins EK; Macheda T; Sanders L; Roberts KN; Shahidehpour RK; Blalock EM; Quan N; Bachstetter AD
    J Neuroinflammation; 2023 Oct; 20(1):248. PubMed ID: 37884959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior.
    Wohleb ES; Patterson JM; Sharma V; Quan N; Godbout JP; Sheridan JF
    J Neurosci; 2014 Feb; 34(7):2583-91. PubMed ID: 24523548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury.
    Basu A; Krady JK; O'Malley M; Styren SD; DeKosky ST; Levison SW
    J Neurosci; 2002 Jul; 22(14):6071-82. PubMed ID: 12122068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 1 type 1 receptor restore: a genetic mouse model for studying interleukin 1 receptor-mediated effects in specific cell types.
    Liu X; Yamashita T; Chen Q; Belevych N; Mckim DB; Tarr AJ; Coppola V; Nath N; Nemeth DP; Syed ZW; Sheridan JF; Godbout JP; Zuo J; Quan N
    J Neurosci; 2015 Feb; 35(7):2860-70. PubMed ID: 25698726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive microglia and IL1β/IL-1R1-signaling mediate neuroprotection in excitotoxin-damaged mouse retina.
    Todd L; Palazzo I; Suarez L; Liu X; Volkov L; Hoang TV; Campbell WA; Blackshaw S; Quan N; Fischer AJ
    J Neuroinflammation; 2019 Jun; 16(1):118. PubMed ID: 31170999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection.
    Lazovic J; Basu A; Lin HW; Rothstein RP; Krady JK; Smith MB; Levison SW
    Stroke; 2005 Oct; 36(10):2226-31. PubMed ID: 16179572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury.
    Basu A; Lazovic J; Krady JK; Mauger DT; Rothstein RP; Smith MB; Levison SW
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):17-29. PubMed ID: 15678109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of NLRP3-IL-1β Signals in Cerebral Ischemia and Reperfusion Injury: from Microglia to Adjacent Neuron and Endothelial Cells via IL-1β/IL-1R1/TRAF6.
    Pan J; Peng J; Li X; Wang H; Rong X; Peng Y
    Mol Neurobiol; 2023 May; 60(5):2749-2766. PubMed ID: 36717480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional Knockout of IL-1R1 in Endothelial Cells Attenuates Seizures and Neurodegeneration via Inhibiting Neuroinflammation Mediated by Nrf2/HO-1/NLRP3 Signaling in Status Epilepticus Model.
    Wu L; Zhu Y; Qin Y; Yuan H; Zhang L; Lu T; Chen Q; Hu A
    Mol Neurobiol; 2024 Jul; 61(7):4289-4303. PubMed ID: 38087170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling Between Interleukin-1R1 and Necrosome Complex Involves in Hemin-Induced Neuronal Necroptosis After Intracranial Hemorrhage.
    Chu X; Wu X; Feng H; Zhao H; Tan Y; Wang L; Ran H; Yi L; Peng Y; Tong H; Liu R; Bai W; Shi H; Li L; Huo D
    Stroke; 2018 Oct; 49(10):2473-2482. PubMed ID: 30355103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
    J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced fear memory after social defeat in mice is dependent on interleukin-1 receptor signaling in glutamatergic neurons.
    Goodman EJ; Biltz RG; Packer JM; DiSabato DJ; Swanson SP; Oliver B; Quan N; Sheridan JF; Godbout JP
    Mol Psychiatry; 2024 Aug; 29(8):2321-2334. PubMed ID: 38459193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent Actions of Renal Tubular and Endothelial Type 1 IL-1 Receptor Signaling in Toxin-Induced AKI.
    Ren J; Liu K; Wu B; Lu X; Sun L; Privratsky JR; Xing C; Robson MJ; Mao H; Blakely RD; Abe K; Souma T; Crowley SD
    J Am Soc Nephrol; 2023 Oct; 34(10):1629-1646. PubMed ID: 37545036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities.
    Liu X; Nemeth DP; McKim DB; Zhu L; DiSabato DJ; Berdysz O; Gorantla G; Oliver B; Witcher KG; Wang Y; Negray CE; Vegesna RS; Sheridan JF; Godbout JP; Robson MJ; Blakely RD; Popovich PG; Bilbo SD; Quan N
    Immunity; 2019 Feb; 50(2):317-333.e6. PubMed ID: 30683620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.
    Parpaleix A; Amsellem V; Houssaini A; Abid S; Breau M; Marcos E; Sawaki D; Delcroix M; Quarck R; Maillard A; Couillin I; Ryffel B; Adnot S
    Eur Respir J; 2016 Aug; 48(2):470-83. PubMed ID: 27418552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 mediates thermal injury-induced lung damage through C-Jun NH2-terminal kinase signaling.
    Chen LW; Chang WJ; Wang JS; Hsu CM
    Crit Care Med; 2007 Apr; 35(4):1113-22. PubMed ID: 17334237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
    Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
    Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-19 alleviates brain injury by anti-inflammatory effects in a mice model of focal cerebral ischemia.
    Xie W; Fang L; Gan S; Xuan H
    Brain Res; 2016 Nov; 1650():172-177. PubMed ID: 27608956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 causes CNS inflammatory cytokine expression via endothelia-microglia bi-cellular signaling.
    Zhu L; Liu X; Nemeth DP; DiSabato DJ; Witcher KG; Mckim DB; Oliver B; Le X; Gorantla G; Berdysz O; Li J; Ramani AD; Chen Z; Wu D; Godbout JP; Quan N
    Brain Behav Immun; 2019 Oct; 81():292-304. PubMed ID: 31228609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.